tianjin chase sun pharmaceutical released the third quarter report for 2024, achieving revenue of 4.441 billion yuan in the first three quarters, a year-on-year decrease of 9.78%; net income attributable to shareholders of the listed company was 0.168 billion yuan, a year-on-year decrease of 66.94%. In the third quarter, revenue was 1.445 billion yuan, a year-on-year decrease of 3.61%; net income attributable to shareholders of the listed company was 20.1245 million yuan, a year-on-year decrease of 87.68%.
红日药业：前三季度净利润1.68亿元 同比下降66.94%
tianjin chase sun pharmaceutical: Net income in the first three quarters was 0.168 billion yuan, a year-on-year decrease of 66.94%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated